Having a validated manufacturing capability and capacity in place ahead of human clinical trials has been a priority.
With a wholly owned automated manufacturing facility now established in Sydney Australia. Recce Pharmaceuticals is well placed to produce product in volumes to support planned Phase 1 and Phase 2 clinical trials.
Our Sydney facility is supported by a second manual manufacturing facility in Perth, Western Australia.
The new Sydney facility is purpose built to meet the pharmaceutical standards set by international regulatory agencies in the US, Europe and Australia.